Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to people with visual disabilities who are using a screen reader; Press Control-F10 to open an accessibility menu.

Vismodegib (Erivedge): Revision history

From EyeWiki

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

January 30, 2025

August 2, 2024

February 2, 2024

September 26, 2023

July 31, 2023

July 4, 2023

March 7, 2023

November 3, 2022

April 10, 2022

September 3, 2021

January 24, 2021

July 10, 2020

January 11, 2020

July 31, 2019

February 21, 2019

March 22, 2018

November 7, 2017

September 3, 2015

December 13, 2014

September 30, 2014

November 6, 2012

November 5, 2012

  • curprev 18:0018:00, November 5, 2012Ako.Takakura talk contribs 9,575 bytes +9,575 Created page with 'Vismodegib (Erivedge) is a molecular inhibitor of the Hedgehog signaling pathway. It was developed by Genentech and approved by the FDA in January 2012 for the treatment of metas…'
The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.
Blanking
content model change
Manual revert
MassMessage delivery
New redirect
Redirect target changed
Removed redirect
Replaced
Reverted
Rollback
Undo
Visual edit
Visual edit: Switched
wikieditor (hidden tag)